Latham & Watkins advises eFFECTOR Therapeutics in US$7.5 million registered direct offering. eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised the bank consortium on the maturity extension of the €2.7 billion revolving credit facilities (RCF) for travel group TUI by a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents The Vita Coco Company, Inc. in upsized secondary offering of common stock by selling stockholder. The Vita Coco Company, Inc., a leading...
You must be a Standard 1 Year member to access this content.
Latham & Watkins’ capital markets team represents the underwriter in the offering by the leading foodservice distributor. US Foods Holding Corp. has announced the pricing of a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
In the transaction, the Permira funds were assisted by Legance, Latham & Watkins, Clifford Chance and Maisto e Associati; Gruppo Florence sellers are supported by GOP,...
You must be a Standard 1 Year member to access this content.
Milbank advised Cedacri on the offering, Latham & Watkins advised BNP Paribas and UniCredit Bank AG. Cedacri S.p.A. announced its issuance of €275 million senior secured...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus advised EVgo, and Latham & Watkins advised the underwriters. EVgo Inc. announced the pricing on May 17, 2023 of an underwritten public offering of 29,411,765...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Protective Industrial Products on the deal. Protective Industrial Products, Inc (PIP®), a portfolio company of Odyssey Investment Partners, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Icosavax on the offering. Icosavax, Inc. (Nasdaq: ICVX) has announced that it has entered into a securities purchase agreement with investors in a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented NewLimit in the financing. NewLimit has announced that it has raised $40 million in a Series A funding round from Dimension, Founders Fund,...
You must be a Standard 1 Year member to access this content.
Proskauer Rose advised Intapp, Latham & Watkins advised the underwriters, Sidley Austin advised Great Hill Equity Partners IV, L.P. and its affiliates, and Morrison & Foerster...
You must be a Standard 1 Year member to access this content.
